Inhibition of 5αR2 promotes postoperative wound repair in BPH patients after TURP by alleviating fibrosis and inflammation
Asian Journal of Andrology · 2026
DOI: 10.4103/aja202561 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Asian Journal of Andrology, 2026. Verfasst von Cheng-Hao Zheng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai 200080, China. Hauptthemen laut MEDLINE: Prostatic Hyperplasia, Transurethral Resection of Prostate, Wound Healing, 5-alpha Reductase Inhibitors. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Postoperative wound repair after transurethral resection of the prostate (TURP) in benign prostatic hyperplasia (BPH) patients is crucial for reducing complications and promoting recovery. Androgens, particularly dihydrotestosterone (DHT), influence prostatic development and wound healing, with type II 5α-reductase (5αR2) playing a key role in DHT synthesis. In this study, the effects of type II 5α-reductase inhibitors (5-ARIs) on postoperative healing, inflammation control, and fibrosis reduction were evaluated. A double-blinded randomized clinical trial was performed to assess 87 BPH patients treated with type II 5-ARIs ( n = 47) or placebo ( n = 42) over six months. The type II 5-ARIs group presented a 55.0% lower complication rate ( P = 0.002), with reduced hematuria (0 vs 7.1%, P = 0.046) and catheter reintroduction (0 vs 9.5%, P = 0.025). An animal study using 12 beagles was performed, and molecular markers were analyzed via single-cell RNA sequencing, enzyme-linked immunosorbent assay (ELISA), and histology. 5αR2 inhibition accelerated urothelial regeneration, decreased inflammation, and reduced myofibroblast activation by 42.0% while increasing the expression of the urothelial marker uroplakin 3A (UPK3A) by 67.0%. Organoid experiments confirmed increased urothelial differentiation and reduced glandular epithelial expansion with type II 5-ARI treatment. These findings suggest that 5αR2 inhibition promotes TURP postoperative recovery in BPH patients by reducing inflammation, inhibiting fibrosis, and promoting wound repair. These findings support the use of type II 5-ARIs as potential adjuvant therapies for optimizing BPH patient postoperative outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai 200080, China.
Zitieren
APA
Zheng, C. H., Wang, W. H., Ji, S. Y., Jing, Y. F., Han, B. M., Xia, S. J., & Wang, X. J. (2026). Inhibition of 5αR2 promotes postoperative wound repair in BPH patients after TURP by alleviating fibrosis and inflammation. Asian Journal of Andrology. https://doi.org/10.4103/aja202561
Vancouver
Zheng CH, Wang WH, Ji SY, Jing YF, Han BM, Xia SJ, et al. Inhibition of 5αR2 promotes postoperative wound repair in BPH patients after TURP by alleviating fibrosis and inflammation. Asian Journal of Andrology. 2026. doi:10.4103/aja202561
BibTeX
@article{Zheng2026,
author = {Zheng, Cheng-Hao and Wang, Wen-Hao and Ji, Shi-Yu and Jing, Yi-Feng and Han, Bang-Min and Xia, Shu-Jie and Wang, Xing-Jie},
title = {Inhibition of 5αR2 promotes postoperative wound repair in BPH patients after TURP by alleviating fibrosis and inflammation},
journal = {Asian Journal of Andrology},
year = {2026},
doi = {10.4103/aja202561}
}
EUVIMED